Bingbing Song
Loma Linda, CANPI 1033400460
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $723,431 of the $723,431 with a category attached, or 100.0%. Roche Molecular Systems, Inc. accounts for 77.3% of it on its own, with 1 other manufacturer making up the rest.
$723,431in general payments, 2019–2025
Across 62 payments — averaging $11,668 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Molecular Systems, Inc.$559K
- Ventana Medical Systems, Inc.$164K
What the payments were for
- Speaking & faculty fees$723,431100%
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Molecular Systems, Inc. | 33 | $559,362 |
| Ventana Medical Systems, Inc. | 29 | $164,069 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.